Arizona will get more than $380 million from national opioid settlement

Arizona will receive more than $380 million from a national opioid settlement with drug makers Teva and Allergan, as well as CVS and Walgreens pharmacies, Attorney General Kris Mayes announced on Thursday.

"These agreements mark a significant step forward in Arizona's efforts to combat the devastating effects of the opioid crisis on individuals, families, and communities across our state," Mayes said in a prepared statement. "While no amount of money can fully make up for the disastrous impact opioids have had on Arizonans, these dollars will play a crucial role in helping communities meet the needs of those suffering from this crisis.”

Mayes said Arizona will get the money over the course of 15 years, with $213 million going to local governments and $167 million dedicated to the state level. The money was expected to start flowing by the end of 2023.

As part of the settlement conditions, Teva will no longer be able to market opioids, Allergan must stop selling opioids for 10 years, and CVS and Walgreens agreed to stricter monitoring and reporting of suspicious activity related to opioid prescriptions.

Mayes' office said Arizona's total share of national litigation against the pharmaceutical industry over the opioid crisis is now more than $1.1 billion.

Arizona is set to get more than a half billion dollars as part of an opioid settlement with pharmaceutical distributors and Johnson & Johnson.

This article originally appeared on Arizona Republic: Arizona opioid settlement announced